Dialogue Health Technologies (OTCMKTS:DLHTF) PT Lowered to C$3.50

Dialogue Health Technologies (OTCMKTS:DLHTFGet Rating) had its price target decreased by TD Securities from C$4.50 to C$3.50 in a report published on Wednesday, The Fly reports.

Several other equities research analysts also recently issued reports on the company. National Bank Financial lowered their price target on Dialogue Health Technologies from C$11.50 to C$8.50 in a research report on Tuesday, August 9th. Royal Bank of Canada decreased their target price on Dialogue Health Technologies from C$7.00 to C$6.00 in a research report on Monday, August 15th. Finally, Scotiabank decreased their target price on Dialogue Health Technologies from C$8.50 to C$8.00 in a research report on Friday, August 12th.

Dialogue Health Technologies Trading Down 11.5 %

Shares of OTCMKTS:DLHTF opened at 2.07 on Wednesday. Dialogue Health Technologies has a 52-week low of 2.07 and a 52-week high of 4.75.

Dialogue Health Technologies Company Profile

(Get Rating)

Dialogue Health Technologies Inc operates a digital healthcare and wellness platform in Canada Germany, and Australia. Its Integrated Health Platform is a healthcare hub that centralizes its programs in a single user-friendly application, which provide access to psychologists, psychotherapists, social workers, physicians, nurses, and health specialists.

See Also

The Fly logo

Receive News & Ratings for Dialogue Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dialogue Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.